101
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Risk Factors for Post-Pancreaticoduodenectomy Mortality: Identification and Mitigation

ORCID Icon &
Pages 63-71 | Received 02 Dec 2023, Accepted 08 Apr 2024, Published online: 18 Apr 2024

References

  • Whipple AO. Pancreaticoduodenectomy for islet carcinoma. Ann Surg. 1945;121(6):847–852. doi:10.1097/00000658-194506000-00008
  • Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244(1):10–15. doi:10.1097/01.sla.0000217673.04165.ea
  • Grace PA, Pitt HA, Tompkins RK, DenBesten L, Longmire WP. Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg. 1986;151(1):141–149. doi:10.1016/0002-9610(86)90024-3
  • Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the whipple procedure. Ann Surg. 1987;206(3):358–365. doi:10.1097/00000658-198709000-00014
  • Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg. 2015;220(4):530–536. doi:10.1016/j.jamcollsurg.2014.12.031
  • Narayanan S, Martin AN, Turrentine FE, Bauer TW, Adams RB, Zaydfudim VM. Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death. J Surg Res. 2018;231:304–308. doi:10.1016/j.jss.2018.05.075
  • Vollmer CM, Sanchez N, Gondek S, et al. A root-cause analysis of mortality following major pancreatectomy. J Gastrointestinal Surg. 2012;16(1):89–103. doi:10.1007/s11605-011-1753-x
  • Hill JS, Zhou Z, Simons JP, et al. A simple risk score to predict in-hospital mortality after pancreatic resection for cancer. Ann Surg Oncol. 2010;17(7):1802–1807. doi:10.1245/s10434-010-0947-x
  • Venkat R, Puhan MA, Schulick RD, et al. Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. Arch Surg. 2011;146(11):1277–1284. doi:10.1001/archsurg.2011.294
  • Ragulin-Coyne E, Carroll JE, Smith JK, et al. Perioperative mortality after pancreatectomy: a risk score to aid decision-making. Surgery. 2012;152(3 Suppl 1):S120–7. doi:10.1016/j.surg.2012.05.018
  • Gleeson EM, Shaikh MF, Shewokis PA, et al. WHipple-ABACUS, a simple, validated risk score for 30-day mortality after pancreaticoduodenectomy developed using the ACS-NSQIP database. Surgery. 2016;160(5):1279–1287. doi:10.1016/j.surg.2016.06.040
  • Greenblatt DY, Kelly KJ, Rajamanickam V, et al. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol. 2011;18(8):2126–2135. doi:10.1245/s10434-011-1594-6
  • Kang JS, Kim H, Kim JR, et al. Short- and long-term outcomes of pancreaticoduodenectomy in elderly patients with periampullary cancer. Ann Surg Treat Res. 2020;98(1):7. doi:10.4174/astr.2020.98.1.7
  • Lee DY, Schwartz JA, Wexelman B, Kirchoff D, Yang KC, Attiyeh F. Outcomes of pancreaticoduodenectomy for pancreatic malignancy in octogenarians: an American College of surgeons national surgical quality improvement program analysis. Am J Surg. 2014;207(4):540–548. doi:10.1016/j.amjsurg.2013.07.042
  • Johansen KU, Lundgren LM, Gasslander TR, Sandström P, Björnsson B. There is no increase in perioperative mortality after pancreaticoduodenectomy in octogenarians: results from the Swedish national registry for tumors in the pancreatic and periampullary region. Annals of Surgery Open. 2020;1(2):e015. doi:10.1097/AS9.0000000000000015
  • Pędziwiatr M, Małczak P, Mizera M, et al. Pancreatoduodenectomy for pancreatic head tumors in the elderly – systematic review and meta-analysis. Surg Oncol. 2018;27(3):346–364. doi:10.1016/j.suronc.2018.05.021
  • Li V, Awan A, Serrano PE. Frailty predicts postoperative complications following pancreaticoduodenectomy. Eur Surg Res. 2022;63(4):232–240. doi:10.1159/000522576
  • Mogal H, Vermilion SA, Dodson R, et al. Modified frailty index predicts morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol. 2017;24(6):1714–1721. doi:10.1245/s10434-016-5715-0
  • Hamidi M, O’Grady CL, Brown SD, et al. Does preoperative Estimated Glomerular Filtration Rate (eGFR) predict short-term surgical outcomes in patients undergoing pancreatic resections? J Gastrointestinal Surg. 2022;26(4):861–868. doi:10.1007/s11605-021-05179-8
  • Patnaik R, Khan MTA, Spencer I, Aziz H. Chronic kidney disease classification predicts short-term outcomes of patients undergoing pancreaticoduodenectomy. J Gastrointestinal Surg. 2022;26(12):2534–2541. doi:10.1007/s11605-022-05512-9
  • Nakeeb AE. Impact of cirrhosis on surgical outcome after pancreaticoduodenectomy. World J Gastroenterol. 2013;19(41):7129. doi:10.3748/wjg.v19.i41.7129
  • Enderes J, Teschke J, Manekeller S, Vilz TO, Kalff JC, Glowka TR. Chronic liver disease increases mortality following pancreatoduodenectomy. J Clin Med. 2021;10(11):2521. doi:10.3390/jcm10112521
  • Chang EH, Sugiyama G, Smith MC, et al. Obesity and surgical complications of pancreaticoduodenectomy: an observation study utilizing ACS NSQIP. Am J Surg. 2020;220(1):135–139. doi:10.1016/j.amjsurg.2019.10.030
  • El Nakeeb A, Hamed H, Shehta A, et al. Impact of obesity on surgical outcomes post-pancreaticoduodenectomy: a case-control study. Int j Surg. 2014;12(5):488–493. doi:10.1016/j.ijsu.2014.01.017
  • Zorbas Konstantinos A, Wu J, Reddy Sanjay S, Esnaola Nestor F, Karachristos A. Obesity affects outcomes of pancreatoduodenectomy. Pancreatology. 2021. doi:10.1016/j.pan.2021.02.019
  • Gazivoda VP, Greenbaum A, Beier MA, et al. Pancreatoduodenectomy: the metabolic syndrome is associated with preventable morbidity and mortality. J Gastrointestinal Surg. 2022;26(10):2167–2175. doi:10.1007/s11605-022-05386-x
  • Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms. J Gastrointestinal Surg. 2015;19(6):1072–1077. doi:10.1007/s11605-015-2799-y
  • Gomes RM, Bal M, Patkar S, Goel M, Shrikhande SV. Unexpected benign histopathology after pancreatoduodenectomy for presumed malignancy: accepting the inevitable. Langenbecks Arch Surg. 2016;401(2):169–179. doi:10.1007/s00423-016-1372-9
  • Mavroeidis V, Russell T, Clark J, et al. Pancreatoduodenectomy for suspected malignancy: nonmalignant histology confers increased risk of serious morbidity. Ann R Coll Surg Engl. 2023;105(5):446–454. doi:10.1308/rcsann.2022.0055
  • Aploks K, Kim M, Stroever S, et al. Radiation therapy prior to a pancreaticoduodenectomy for adenocarcinoma is associated with longer operative times and higher blood loss. World J Gastrointest Surg. 2023;15(8):1663–1672.
  • Davis CH, Beane JD, Gazivoda VP, et al. Neoadjuvant therapy for pancreatic cancer: increased use and improved optimal outcomes. J Am Coll Surg. 2022;234(4):436–443. doi:10.1097/XCS.0000000000000095
  • Cools KS, Sanoff HK, Kim HJ, Yeh JJ, Stitzenberg KB. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy. J Surg Oncol. 2018;118(3):455–462. doi:10.1002/jso.25183
  • Franko J, Hsu HW, Thirunavukarasu P, Frankova D, Goldman CD. Chemotherapy and radiation components of neoadjuvant treatment of pancreatic head adenocarcinoma: impact on perioperative mortality and long-term survival. Eur J Surg Oncol. 2017;43(2):351–357. doi:10.1016/j.ejso.2016.10.021
  • Sosa JA, Bowman HM, Gordon TA, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998;228(3):429–438. doi:10.1097/00000658-199809000-00016
  • Hata T, Motoi F, Ishida M, et al. Effect of hospital volume on surgical outcomes after pancreaticoduodenectomy. Ann Surg. 2016;263(4):664–672. doi:10.1097/SLA.0000000000001437
  • Gooiker GA, Lemmens VEPP, Besselink MG, et al. Impact of centralization of pancreatic cancer surgery on resection rates and survival. Br J Surg. 2014;101(8):1000–1005. doi:10.1002/bjs.9468
  • Gooiker GA, van Gijn W, Wouters MWJM, Post PN, van de Velde CJH, Tollenaar RAEM. Systematic review and meta-analysis of the volume–outcome relationship in pancreatic surgery. Br J Surg. 2011;98(4):485–494. doi:10.1002/bjs.7413
  • Nassour I, Wang SC, Christie A, et al. Minimally invasive versus open pancreaticoduodenectomy. Ann Surg. 2018;268(1):151–157. doi:10.1097/SLA.0000000000002259
  • Wang M, Cai H, Meng L, et al. Minimally invasive pancreaticoduodenectomy: a comprehensive review. Int j Surg. 2016;35:139–146. doi:10.1016/j.ijsu.2016.09.016
  • Doula C, Kostakis ID, Damaskos C, et al. Comparison Between minimally invasive and open pancreaticoduodenectomy. Surg Laparosc Endosc Percutan Tech. 2016;26(1):6–16. doi:10.1097/SLE.0000000000000228
  • Tran TB, Dua MM, Worhunsky DJ, Poultsides GA, Norton JA, Visser BC. The first decade of laparoscopic pancreaticoduodenectomy in the United States: costs and outcomes using the nationwide inpatient sample. Surg Endosc. 2016;30(5):1778–1783. doi:10.1007/s00464-015-4444-y
  • Adam MA, Choudhury K, Dinan MA, et al. Minimally invasive versus open pancreaticoduodenectomy for cancer. Ann Surg. 2015;262(2):372–377. doi:10.1097/SLA.0000000000001055
  • Sharpe SM, Talamonti MS, Wang CE, et al. Early National experience with laparoscopic pancreaticoduodenectomy for ductal adenocarcinoma: a comparison of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy from the national cancer data base. J Am Coll Surg. 2015;221(1):175–184. doi:10.1016/j.jamcollsurg.2015.04.021
  • Zhang H, Wu X, Zhu F, et al. Systematic review and meta-analysis of minimally invasive versus open approach for pancreaticoduodenectomy. Surg Endosc. 2016;30(12):5173–5184. doi:10.1007/s00464-016-4864-3
  • de Rooij T, Lu MZ, Steen MW, et al. Minimally Invasive Versus Open Pancreatoduodenectomy. Ann Surg. 2016;264(2):257–267. doi:10.1097/SLA.0000000000001660
  • van Hilst J, de Rooij T, Bosscha K, et al. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial. Lancet Gastroenterol Hepatol. 2019;4(3):199–207. doi:10.1016/S2468-1253(19)30004-4
  • Yu XZ, Li J, Fu DL, et al. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis. Eur J Surg Oncol. 2014;40(4):371–378. doi:10.1016/j.ejso.2014.01.010
  • Castleberry AW, White RR, De la Fuente SG, et al. The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American college of surgeons national surgical quality improvement program database. Ann Surg Oncol. 2012;19(13):4068–4077. doi:10.1245/s10434-012-2585-y
  • Zettervall SL, Ju T, Holzmacher JL, et al. Arterial, but not venous, reconstruction increases 30-day morbidity and mortality in pancreaticoduodenectomy. J Gastrointestinal Surg. 2020;24(3):578–584. doi:10.1007/s11605-019-04211-2
  • Pastrana Del Valle J, Mahvi DA, Fairweather M, et al. The improvement in post-operative mortality following pancreaticoduodenectomy between 2006 and 2016 is associated with an improvement in the ability to rescue patients after major morbidity, not in the rate of major morbidity. HPB. 2021;23(3):434–443. doi:10.1016/j.hpb.2020.07.013
  • Amini N, Spolverato G, Kim Y, Pawlik TM. Trends in hospital volume and failure to rescue for pancreatic surgery. J Gastrointestinal Surg. 2015;19(9):1581–1592. doi:10.1007/s11605-015-2800-9
  • Gleeson EM, Pitt HA. Failure to rescue after the whipple. Adv Surg. 2022;56(1):1–11. doi:10.1016/j.yasu.2022.02.001
  • Gleeson EM, Clarke JR, Morano WF, Shaikh MF, Bowne WB, Pitt HA. Patient-specific predictors of failure to rescue after pancreaticoduodenectomy. HPB. 2019;21(3):283–290. doi:10.1016/j.hpb.2018.07.022
  • Silber JH, Williams SV, Krakauer H, Schwartz S. Hospital and patient characteristics associated with death after surgery. Med Care. 1992;30(7):615–629. doi:10.1097/00005650-199207000-00004
  • Bundred JR, Kamarajah SK, Hammond JS, Wilson CH, Prentis J, Pandanaboyana S. Prehabilitation prior to surgery for pancreatic cancer: a systematic review. Pancreatology. 2020;20(6):1243–1250. doi:10.1016/j.pan.2020.07.411
  • Barberan-Garcia A, Ubré M, Roca J, et al. Personalised prehabilitation in high-risk patients undergoing elective major abdominal surgery. Ann Surg. 2018;267(1):50–56. doi:10.1097/SLA.0000000000002293
  • Ausania F, Senra P, Meléndez R, Caballeiro R, Ouviña R, Casal-Núñez E. Prehabilitation in patients undergoing pancreaticoduodenectomy: a randomized controlled trial. Revista Española de Enfermedades Digestivas. 2019;111. doi:10.17235/reed.2019.6182/2019
  • Smits FJ, Henry AC, Besselink MG, et al. Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trial. Lancet. 2022;399(10338):1867–1875. doi:10.1016/S0140-6736(22)00182-9